137 related articles for article (PubMed ID: 35113757)
21. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
Zhang Q; Fan X; Tian M; Han H
BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
[TBL] [Abstract][Full Text] [Related]
22. Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine.
De Domingo B; López M; Lopez-Valladares M; Ortegon-Aguilar E; Sopeña-Perez-Argüelles B; Gonzalez F
Cells; 2022 Mar; 11(6):. PubMed ID: 35326462
[TBL] [Abstract][Full Text] [Related]
23. Vogt-Koyanagi-Harada syndrome in a 10-year-old child.
Ghosh AK; Bhaduri G; Deb A; Singh M; Das K
J Indian Med Assoc; 2007 Apr; 105(4):210, 212. PubMed ID: 17822191
[TBL] [Abstract][Full Text] [Related]
24. TATTOO-ASSOCIATED CASES OF POSTERIOR SEGMENT UVEITIS WITH VOGT-KOYANAGI-HARADA DISEASE-LIKE FEATURES.
Kesav NP; Kaplan AJ; Hwang CK; Okeagu C; Sen HN
Retin Cases Brief Rep; 2022 Jul; 16(4):457-460. PubMed ID: 32502130
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal Steroid Treatment for Uveitis Associated with Dabrafenib and Trametinib for Metastatic Cutaneous Melanoma.
Woltsche N; Kruger MA; Weger M; Wolf IH; Seidel G
Ocul Immunol Inflamm; 2021 Jul; 29(5):845-847. PubMed ID: 31906779
[No Abstract] [Full Text] [Related]
26. Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
Ushio R; Yamamoto M; Miyasaka A; Muraoka T; Kanaoka H; Tamura H; Kaneko A; Izawa A; Hirama N; Teranishi S; Manabe S; Inoue T; Shibata K; Sugiura Y; Kudo M; Kaneko T
Intern Med; 2021 Nov; 60(22):3593-3598. PubMed ID: 34092725
[TBL] [Abstract][Full Text] [Related]
27. Vogt-Koyanagi-Harada syndrome in a 4-year old child.
Cunningham ET; Demetrius R; Frieden IJ; Emery HM; Irvine AR; Good WV
Am J Ophthalmol; 1995 Nov; 120(5):675-7. PubMed ID: 7485374
[TBL] [Abstract][Full Text] [Related]
28. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
29. Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.
Draganova D; Kerger J; Caspers L; Willermain F
J Ophthalmic Inflamm Infect; 2015; 5():17. PubMed ID: 26078801
[TBL] [Abstract][Full Text] [Related]
30. Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma.
Crosson JN; Laird PW; Debiec M; Bergstrom CS; Lawson DH; Yeh S
J Immunother; 2015; 38(2):80-4. PubMed ID: 25658618
[TBL] [Abstract][Full Text] [Related]
31. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
32. Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
Lim J; Lomax AJ; McNeil C; Harrisberg B
Ocul Immunol Inflamm; 2018; 26(4):628-631. PubMed ID: 27892777
[TBL] [Abstract][Full Text] [Related]
33. Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient.
Arai T; Harada K; Usui Y; Irisawa R; Tsuboi R
J Dermatol; 2017 Aug; 44(8):975-976. PubMed ID: 27649838
[No Abstract] [Full Text] [Related]
34. Incomplete Vogt-Koyanagi-Harada disease following treatment with encorafenib and binimetinib for metastatic melanoma.
Diamantopoulos PT; Stoungioti S; Anastasopoulou A; Papaxoinis G; Gogas H
Melanoma Res; 2018 Dec; 28(6):648-651. PubMed ID: 30169430
[TBL] [Abstract][Full Text] [Related]
35. Bilateral acute angle closure glaucoma as an initial presentation of Vogt-Koyanagi-Harada syndrome: A clinical case report.
Yuan F; Zhang Y; Yan X
Eur J Ophthalmol; 2022 Jan; 32(1):NP230-NP234. PubMed ID: 32811185
[TBL] [Abstract][Full Text] [Related]
36. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
[TBL] [Abstract][Full Text] [Related]
37. Vogt-Koyanagi-Harada syndrome. A case report.
Iversen TH; Sverrisson T
Acta Ophthalmol (Copenh); 1986 Apr; 64(2):235-8. PubMed ID: 3727967
[TBL] [Abstract][Full Text] [Related]
38. [Bilateral Nivolumab-associated Vogt-Koyanagi-Harada-like Uveitis in a Patient with Metastatic Renal Cell Carcinoma].
Czichos C; Wawrzynów B; Chamalis C; von Jagow B
Klin Monbl Augenheilkd; 2021 Jun; 238(6):711-714. PubMed ID: 33395707
[No Abstract] [Full Text] [Related]
39. Conjunctival nodules associated with Vogt-Koyanagi-Harada disease.
Nakao K; Shimonagano Y; Doi N; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1383-6. PubMed ID: 17701198
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
